Fundraising Growth VETS is a mid-sized non-profit with substantial funding history (over 124M in reported funding to date) and a current revenue range of 10M-25M, indicating strong donor networks and potential for expanded partnerships with pharmaceutical, research, and philanthropic funders focused on psychedelic-assisted therapies.

Research Collaboration Active collaborations with Columbia Psychiatry and ongoing MDMA-assisted therapy studies suggest opportunities to co fund, co sponsor, or provide research services and data management support through platforms like HubSpot Analytics, Salesforce, and iCIMS.

Advocacy & Policy With a dedicated legislative director and a history of policy reform advocacy, there is potential to offer policy analysis, stakeholder engagement programs, and advocacy automations to scale legislative impact for psychedelic therapies and veteran health policies.

Leadership Platform Co-founder Amber Capone’s recognition on the Female Founders list enhances credibility for partner outreach, enabling targeted engagements with mission-aligned investors, corporate sponsors, and media opportunities to amplify funding and visibility.

Strategic Partnerships Recent partnerships including TARA Mind and Helus Pharma, along with ambassador and strengths initiatives, indicate a readiness to expand collaboration channels; sales opportunities exist in alliance programs, ambassador networks, and technology-enabled stakeholder engagement tools.